Chronic blockade of NO synthase paradoxically increases islet NO production and modulates islet hormone release

American Journal of Physiology - Endocrinology and Metabolism

Volumn 279, Issue 1 42-1, 2000, Pages

  Henningsson, Ragnar ^a   Alm, Per ^a   Lindström, Erik ^a   Lundquist, Ingmar ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Chronic nitric oxide synthase blockade; Cyclic nucleotides; Insulin and glucagon secretion; Isolated islets; Nitric oxide and carbon monoxide

Indexed keywords

CYCLIC NUCLEOTIDE; GLUCOSE; HEME OXYGENASE; INSULIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GLUCAGON RELEASE; HORMONE RELEASE; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0033867892     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2000.279.1.e95     Document Type: Article

References (59)

1. Glucagon immunoreactivity in plasma from normal and dystrophic mice
2. Evidence for nitric oxide mediated effects on islet hormone secretory phospholipase C signal transduction mechanisms
3. Influence of nitric oxide modulators on cholinergically stimulated hormone release from mouse islets
4. Interaction of the islet nitric oxide system with L-arginine-induced secretion of insulin and glucagon in mice
5. Morphological evidence for the existence of nitric oxide and carbon monoxide pathways in the rat islets of Langerhans: An immunocytochemical and confocal microscopic study
6. Thiols and pancreatic β-cell function: A review
7. +(ATP) channels
8. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase
9. Feedback inhibition of nitric oxide synthase activity by nitric oxide
10. Inhibition of rat cerebellar nitric oxide synthase by 7-nitroindazole and related substituted indazoles
11. Nitric oxide: An ubiquitous messenger
12. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding
13. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in cerebellum
14. Enzymatic microdetermination of glycogen
15. Assay of neuronal nitric oxide synthase by HPLC determination of citrulline
16. Intraislet release of interleukin 1 inhibits β cell function by inducing β cell expression of inducible nitric oxide synthase
17. Cytokines, nitric oxide and insulin secreting cells
18. The effect of nitric oxide donors on insulin secretion, cyclic GMP and cyclic AMP in rat islets of Langerhans and the insulin-secreting cell lines HIT-T15 and RINm5F
19. Is there a role for nitric oxide in β-cell dysfunction and damage in IDDM?
20. An improved method for isolation of mouse pancreatic islets
21. Alterations of insulin response to different β cell secretagogues and pancreatic vascular resistance induced by N(ω) nitro-L-arginine methyl ester
22. A simplified insulin radioimmunoassay method
23. Membrane sulfhydryl groups and pancreatic beta cell recognition of insulin secretagogues
24. Heme oxygenase and carbon monoxide: Regulatory roles in islet hormone release. A biochemical, immunohistochemical and confocal microscopical study
25. Occurrence and putative hormone regulatory function of a constitutive heme oxygenase in rat pancreatic islets
26. Arginine-induced release of insulin is decreased and glucagon increased in parallel with islet NO production
27. Nitric oxide is not involved in the initiation of insulin secretion from rat islets of Langerhans
28. Nitric oxide synthases in mammals
29. Untersuchungen uber die Harnstoffbildung im Tierkorper
30. Mediation of insulin release by cAMP and cGMP in a starved animal model
31. L-Arginine stimulates cyclic guanosine 3',5'-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: Evidence for L-arginine: Nitric oxide synthase
32. The Stimulus-secretion coupling Of glucose-induced insulin release. XX. Fasting: A model for altered glucose recognition by the B-cell
33. Evidence for the involvement of cGMP and protein kinase G in nitric oxide-induced apoptosis in the pancreatic B-cell line HIT-T15
34. Endocrine pancreas in the dystrophic mouse
35. Inhibition of nitric oxide synthesis enhances the expression of inducible nitric oxide synthase mRNA and protein in a model of chronic liver inflammation
36. Insulin within islets is a physiologic glucagon release inhibitor
37. Failure of L-NAME to cause inhibition of nitric oxide synthesis: Role of inducible nitric oxide synthase
38. Pancreatic neuroendocrinology: Peripheral neural mechanisms in the regulation of the islets of Langerhans
39. The nitric oxide system in the endocrine pancreas induces differential effects on the secretion of insulin and glucagon
40. Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretagogues
41. Inhibition of nitric oxide synthase increases arginine-induced insulin release
42. Homologous islet amyloid polypeptide: Effects on plasma levels of glucagon, insulin and glucose in the mouse
43. Insulin secretion in rats with chronic nitric oxide synthase blockade
44. Blood glucose level in mice. Evaluation of a new technique of multiple serial sampling
45. Regulation of glucagon release from pancreatic A-cells
46. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent
47. Islet constitutive nitric oxide synthase: Biochemical determination and regulatory function
48. Signal transduction in islet hormone release: Interaction of nitric oxide with basal and nutrient-induced hormone responses
49. + channels
50. Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides
51. The effect of starvation on tissue adenosine 3'-5' monophosphate levels
52. Nitric oxide donor SIN-1 inhibits insulin release
53. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms
54. S-nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds
55. Oral administration of the nitric oxide biosynthesis inhibitor, N(G)-nitro-L-arginine methyl ester (L-NAME), causes hypertension, but not glucose intolerance or insulin resistance, in rats
56. Human vascular smooth muscle cells express a constitutive nitric oxide synthase that insulin rapidly activates, thus increasing guanosine 3':5'-cyclic monophosphate and adenosine 3':5'cyclic monophosphate concentrations
57. Protective action by hemin against interleukin-1β induced inhibition of rat pancreatic islet function
58. Neural control of the endocrine pancreas
59. 2+, cAMP and diacylglycerol